0
0
Industry
Geography
Report Type
Price
Publication date
Published Date
  • Company Profile

    $295 | February 2024
    Company Profile

    Aspira Womens Health Inc – Company Profile

    Aspira Womens Health Inc (Aspira), formerly Vermillion Inc, is a medical device company. It offers diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, is a simple blood test. Its other products includes OVERA, a second-generation biomarker panel intended to maintain OVA1’s high sensitivity while improving specificity; OVA1plus; Aspira GenetiX, a genetic test for gynecologic cancer risk, with a core focus on female reproductive cancers,...

    Add to Basket
  • Product Insights

    New
    $500 | April 2024
    Product Insights
    New

    Aspira Womens Health Inc Pipeline Insight and Competitive Landscape, 2023

    Empower your strategies with our Aspira Womens Health Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Aspira Womens Health Inc (Aspira), formerly Vermillion Inc, is a medical device company. It offers diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, is a simple blood test. Its other products includes OVERA, a second-generation biomarker panel intended to maintain OVA1’s high...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.